Vertex Pharmaceuticals IncorporatedVRTXNASDAQ
Loading
Net Margin Over TimeExpanding
Percentile Rank71
3Y CAGR-4.2%
5Y CAGR-5.6%
Year-over-Year Change
Net income as a percentage of revenue
3Y CAGR
-4.2%/yr
vs -14.3%/yr prior
5Y CAGR
-5.6%/yr
Consistent
Acceleration
+10.1pp
Accelerating
Percentile
P71
Within normal range
vs 5Y Ago
0.7x
Contraction
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 32.74% | +773.6% |
| 2024 | -4.86% | -113.3% |
| 2023 | 36.68% | -1.4% |
| 2022 | 37.20% | +20.3% |
| 2021 | 30.92% | -29.2% |
| 2020 | 43.70% | +54.6% |
| 2019 | 28.27% | -58.9% |
| 2018 | 68.80% | +549.9% |
| 2017 | 10.59% | +260.8% |
| 2016 | -6.58% | - |